HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 296/3/R567    most recent 90798.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nayeem, M. A. Articles by Mustafa, S. J. Search for Related Content PubMed PubMed Citation Articles by Nayeem, M. A. Articles by Mustafa, S. J.

RECEPTORS AND SIGNALING PATHWAYS

High-salt diet enhances mouse aortic relaxation through adenosine A_2A receptor via CYP epoxygenases

¹Department of Physiology and Pharmacology, Center for Interdisciplinary Research in Cardiovascular Sciences, West Virginia University, Morgantown, West Virginia; ²Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina; ³Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas

Submitted 29 September 2008 ; accepted in final form 19 December 2008

We hypothesize that A_2A adenosine receptors (A_2A AR) promote aortic relaxation in mice through cytochrome P450 (CYP)-epoxygenases and help to avoid salt sensitivity. Aortas from male mice maintained on a high-salt (HS; 7% NaCl) or normal-salt (NS; 0.45% NaCl) diet for 4–5 wks were used. Concentration-response curves (10^–11–10^–5 M) for 5'-N-ethylcarboxamidoadenosine (NECA; a nonselective adenosine analog) and CGS 21680 (A_2A AR agonist) were obtained with different antagonists including ZM 241385 (A_2A AR antagonist; 10^–6 M), SCH 58261 (A_2A AR antagonist; 10^–6 M), N-nitro-L-arginine methyl ester (L-NAME; endothelial nitric oxide synthase inhibitor; 10^–4 M) and inhibitors including methylsulfonyl-propargyloxyphenylhexanamide (MS-PPOH; CYP epoxygenases inhibitor; 10^–5M), 14,15-epoxyeicosa-5(z)-enoic acid (14,15-EEZE; EET antagonist; 10^–5M), dibromo-dodecenyl-methylsulfimide (DDMS; CYP4A inhibitor; 10^–5M), and HET0016 (20-HETE inhibitor; 10^–5M). At 10^–7 M of NECA, significant relaxation in HS (+22.58 ± 3.12%) was observed compared with contraction in NS (–10.62 ± 6.27%, P < 0.05). ZM 241385 changed the NECA response to contraction (P < 0.05) in HS. At 10^–7 M of CGS 21680, significant relaxation in HS (+32.04 ± 3.08%) was observed compared with NS (+10.45 ± 1.34%, P < 0.05). SCH 58261, L-NAME, MS-PPOH, and 14,15-EEZE changed the CGS 21680-induced relaxation to contraction (P < 0.05) in HS. Interestingly, DDMS and HET0016 changed CGS 21680 response to relaxation (P < 0.05) in NS; however, there was no significant difference found between DDMS, HET0016-treated HS and NS vs. nontreated HS group (P > 0.05). CYP2C29 protein was 55% and 74% upregulated in HS vs. NS (P < 0.05) mice aorta and kidney, respectively. CYP4A protein was 30.30% and 35.70% upregulated in NS vs. HS (P < 0.05) mice aorta and kidneys, respectively. A₁ AR was downregulated, whereas A_2A AR was upregulated in HS compared with NS. These data suggest that HS may activate CYP2C29 via A_2A AR, causing relaxation, whereas NS may contribute to the upregulation of CYP4A causing contraction.

vasodilation; vasoconstriction